Xuegang Wu
Ginkgo Pharma Co., Ltd.
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Maria Prins, Prof. dr.
Public Health Service of Amsterdam (GGD Amsterdam)
Shared therapeutic areas:
Camilo Zaks, MD
University of Southern California, Keck School of Medicine of USC, Department of Family Medicine, USC Street Medicine
Shared therapeutic areas:
Marta Vasylyev, MD
Medical Centre Astar
Shared therapeutic areas:
Chia-Yen Dai, M.D., M.S.
Kaohsiung Municipal United Hospital
Shared therapeutic areas:
Darlene Bhavnani, PhD MPH
The University of Texas at Austin Dell Medical School
Shared therapeutic areas:
Javier Hernández Blanco, MD
Asociación Colombiana de Hepatología
Shared therapeutic areas:
George Wu, MD
University of Connecticut
Shared therapeutic areas:
Ming-Lung Yu, M.D., Ph.D.
Kaohsiung Municipal United Hospital
Shared therapeutic areas:
Pablo Tebas, M.D.
University of Pennsylvania
Shared therapeutic areas:
Alberto Sanchez-Fueyo, MD
Hospital Clinic Barcelona / IDIBAPS, Barcelona, Spain
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients
Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients
All 2 trials loaded